Congress temporarily suspends tariffs on imported formula to reduce cost
The Senate today passed and sent to the president for his signature the Formula Act (H.R. 8351), bipartisan legislation that would suspend tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.
Related News Articles
Headline
In this conversation, Jennifer Richards, Ph.D., assistant professor at the Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, and…
Headline
In this conversation, Johnna Nynas, M.D., obstetrician and gynecologist at Sanford Health Bemidji, discusses the dramatic expansion of maternal telehealth…
Chairperson's File
Ensuring all women have the care they need during and after pregnancy is a priority at U.S. hospitals and health systems.You likely know the impetus behind…
Headline
The Health Resources and Services Administration Oct. 9 announced it will award nearly $19 million to 15 states for identifying and implementing maternal…
Headline
In observance of National Hispanic Heritage Month, this conversation focuses on how Chester County Hospital in Pennsylvania deployed bilingual volunteers to…
Headline
The AHA this week launched refreshed webpages dedicated to maternal and child health. The redesigned platform offers three distinct subpages focused on Better…